
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Balance Sheet: Reasonably good balance sheet.
Past Returns: Underperforming stock! In past three years, the stock has provided -12% return compared to 10.2% by NIFTY 50.
Dilution: Company has a tendency to dilute it's stock investors.
Momentum: Stock has a weak negative price momentum.
Smart Money: Smart money is losing interest in the stock.
Technicals: SharesGuru indicator is Bearish.
Valuation | |
|---|---|
| Market Cap | 1.99 kCr |
| Price/Earnings (Trailing) | -32 |
| Price/Sales (Trailing) | 1.1 |
| EV/EBITDA | 18.66 |
| Price/Free Cashflow | -231.97 |
| MarketCap/EBT | -556.34 |
| Enterprise Value | 2.55 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 1.8 kCr |
| Rev. Growth (Yr) | 5.8% |
| Earnings (TTM) | -62.62 Cr |
| Earnings Growth (Yr) | -396.6% |
Profitability | |
|---|---|
| Operating Margin | 1% |
| EBT Margin | 0.00% |
| Return on Equity | -7.28% |
| Return on Assets | -3.07% |
| Free Cashflow Yield | -0.43% |
Growth & Returns | |
|---|---|
| Price Change 1W | 1% |
| Price Change 1M | -23.7% |
| Price Change 6M | -47% |
| Price Change 1Y | -35.2% |
| 3Y Cumulative Return | -12% |
| 5Y Cumulative Return | -5.8% |
| 7Y Cumulative Return | 11.7% |
| 10Y Cumulative Return | 0.40% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -75.35 Cr |
| Cash Flow from Operations (TTM) | 26.72 Cr |
| Cash Flow from Financing (TTM) | 72.44 Cr |
| Cash & Equivalents | 87.44 Cr |
| Free Cash Flow (TTM) | -15.72 Cr |
| Free Cash Flow/Share (TTM) | -0.84 |
Balance Sheet | |
|---|---|
| Total Assets | 2.04 kCr |
| Total Liabilities | 1.18 kCr |
| Shareholder Equity | 860.12 Cr |
| Current Assets | 1.17 kCr |
| Current Liabilities | 856.38 Cr |
| Net PPE | 630.01 Cr |
| Inventory | 530.95 Cr |
| Goodwill | 47.47 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.32 |
| Debt/Equity | 0.75 |
| Interest Coverage | -1.05 |
| Interest/Cashflow Ops | 1.29 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend Yield | 0.15% |
| Shares Dilution (1Y) | 14.7% |
| Shares Dilution (3Y) | 22.3% |
Balance Sheet: Reasonably good balance sheet.
Past Returns: Underperforming stock! In past three years, the stock has provided -12% return compared to 10.2% by NIFTY 50.
Dilution: Company has a tendency to dilute it's stock investors.
Momentum: Stock has a weak negative price momentum.
Smart Money: Smart money is losing interest in the stock.
Technicals: SharesGuru indicator is Bearish.
Investor Care | |
|---|---|
| Dividend Yield | 0.15% |
| Shares Dilution (1Y) | 14.7% |
| Earnings/Share (TTM) | -3.24 |
Financial Health | |
|---|---|
| Current Ratio | 1.36 |
| Debt/Equity | 0.75 |
Technical Indicators | |
|---|---|
| RSI (14d) | 28.02 |
| RSI (5d) | 53.78 |
| RSI (21d) | 32.42 |
| MACD Signal | Buy |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Sell |
| RSI Signal | Buy |
| RSI5 Signal | Hold |
| RSI21 Signal | Hold |
| SMA 5 Signal | Sell |
| SMA 10 Signal | Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
Summary of Camlin Fine Sciences's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Management provided an optimistic outlook regarding future performance, especially in the Vanillin segment. For fiscal year 2027 (FY'27), the company anticipates a total sales volume of 4,000 metric tons of Vanillin, a significant increase from the 1,740 metric tons sold in the first nine months of FY'26. They expect Vanillin realizations to improve to around $14-$14.5 per kg, which is reflective of a 25% tariff reduction.
In terms of financial performance, management projected that overall revenue for the company would reach approximately Rs.2,200 crores in FY'27 and further increase to Rs.2,400 crores in FY'28. They projected EBITDA margins to improve between 12% to 14%, driven by enhanced sales volumes and realizations in the Vanillin segment along with 20%-25% growth in the Blends business.
Key forward-looking points emphasized include:
Overall, management seems confident in maintaining growth trajectories while managing transitioning challenges.
1. Question from Hrushikesh Shah: "Sir, my first question is currently our Vanillin realization at $12, right? And you mentioned that they may increase by $2 to $3. So, according to me, let's say your realization in the US is $18. If your tariffs move down by 25%, then your realization should increase by $6. So, where is the disconnect in this?"
Answer: The price in the US is around $18-$19, which is correct. However, we had to pay 50% duty to realize $12. With the duty reduced to 25%, our realization will improve to about $14-$14.5. This adjustment accounts for local competition without the duty.
2. Question from Hrushikesh Shah: "What is the volume guidance for FY'27?"
Answer: For FY'27, we expect total Vanillin sales, including methyl and ethyl, to be around 4,000 metric tons.
3. Question from Hrushikesh Shah: "What was the revenue for Vinpai for the full year?"
Answer: Vinpai's consolidated revenue has been around Rs. 13 crores monthly, so the annual turnover is approximately Rs. 150 crores.
4. Question from Hrushikesh Shah: "What do you think is our steady-state margin?"
Answer: Our steady-state gross margin should improve to 46%-47% in FY'27 due to increased Vanillin realizations and growth in the blends business. The EBITDA margin is expected to range between 12%-14%.
5. Question from Satish Kumar: "What is the duty right now in the US?"
Answer: The current duty is 25%. Once the trade deal is finalized, we expect this to drop to 18%.
6. Question from Satish Kumar: "What was the quantity of Vanillin we did not sell this quarter?"
Answer: We opted to delay the sale of about 200 tons to benefit from the lower duty in the next quarter, aiming for a better realization.
7. Question from Surya Narayan Patra: "Will Vanillin pricing in the US affect Europe too post-tariff?"
Answer: No, there will be a disparity. The anti-dumping duties in Europe are much higher, meaning pricing dynamics will remain different between the US and Europe.
8. Question from Surya Narayan Patra: "What is the impact of the Brazilian fire incident?"
Answer: While the blending unit is temporarily closed, the incident will not significantly impact our top-line revenue. However, we may face margin pressure short-term due to local sourcing.
9. Question from Rehan: "What would be the margin profile at EBITDA level for Vinpai and the other acquisitions?"
Answer: Vinpai is currently near breakeven with minimal EBITDA contribution, while Vitafor is stable with margins around 4%-12%.
10. Question from Rohan Advant: "What is the revenue guidance for '27 and '28?"
Answer: We are targeting around Rs. 2,200 crores for FY'27, growing to approximately Rs. 2,400 crores in FY'28, assuming current product pricing remains steady.
Understand Camlin Fine Sciences ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Ashish Subhash Dandekar | 10.3% |
| Infinity Direct Holdings | 10.18% |
| Anfima Nv | 8.83% |
| Infinity Holdings | 6.2% |
| Infinity Direct Capital | 4.82% |
| Icici Prudential Commodities Fund | 4.8% |
| Camart Finance Limited | 2.77% |
| Nirmal Vinod Momaya | 1.88% |
| Franklin India Opportunites Fund | 1.69% |
| Anagha Subhash Dandekar | 1.57% |
| Vibha Agencies Pvt Ltd | 1.36% |
| Ajay Upadhyaya | 1.3% |
| Infinity Portfolio Holdings | 1.17% |
| Jagdish N Master | 1% |
| Cafco Consultants Limited | 0.78% |
| Radha Pandit | 0.04% |
| Anand Y Pandit | 0.01% |
| MK Falcon Agro tech Pvt. Ltd. | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Camlin Fine Sciences against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| VINATIORGA | Vinati Organics | 12.53 kCr | 2.31 kCr | -10.30% | -21.70% | 28.29 | 5.43 | - | - |
| JUBLINGREA | Jubilant Ingrevia | 10.22 kCr | 4.3 kCr | +15.00% | +1.10% | 38.16 | 2.38 | - | - |
| SEQUENT | Sequent Scientific | 8.95 kCr | 2.15 kCr | +4.00% | +49.60% | 84.81 | 4.17 | - | - |
| GALAXYSURF | Galaxy Surfactants | 6.39 kCr | 5.11 kCr | +0.50% | -17.60% | 22.77 | 1.25 | - | - |
| BALAMINES | Balaji Amines | 3.51 kCr | 1.41 kCr | +8.10% | -10.20% | 24.46 | 2.48 | - | - |
Comprehensive comparison against sector averages
CAMLINFINE metrics compared to Chemicals
| Category | CAMLINFINE | Chemicals |
|---|---|---|
| PE | -32.07 | 41.87 |
| PS | 1.11 | 3.88 |
| Growth | 7.7 % | 4.8 % |
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
CAMLINFINE vs Chemicals (2021 - 2026)